Charlene Hagen
Nurse Practitioner · Farmington, NMNPI 1306154463
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.8% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $844 and has fallen 50.5% since, to $418 in 2025. Among nurse practitioner clinicians in NM with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 145 payments — averaging $20.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$414
- Boehringer Ingelheim$370
- Astellas Pharma US Inc$330
- Lilly USA, LLC$238
- Novo Nordisk$218
- AbbVie$179
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,87997%
- Education$953%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $414 |
| Boehringer Ingelheim | 17 | $370 |
| Astellas Pharma US Inc | 13 | $330 |
| Lilly USA, LLC | 13 | $238 |
| Novo Nordisk | 13 | $218 |
| AbbVie | 9 | $179 |
| Johnson & Johnson | 8 | $149 |
| Pfizer | 9 | $148 |
| Amgen | 5 | $111 |
| Organon | 2 | $102 |
| GSK | 6 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $81 |
| Ultragenyx Pharmaceutical Inc. | 1 | $64 |
| Myriad Women's Health, Inc. | 1 | $62 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $50 |
| Merck | 3 | $49 |
| Lundbeck LLC | 2 | $46 |
| Mylan Specialty L.p. | 2 | $43 |
| Biohaven Pharmaceuticals, Inc. | 2 | $42 |
| Exact Sciences | 2 | $39 |
| Amarin Pharma, Inc. | 2 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Novartis | 1 | $20 |
| Dexcom, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Boston Scientific | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$2,974 in reported general payments places this provider in the 95th percentile of 624 nurse practitioner providers in New Mexico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 29 | $29,123 |
| OzempicSemaglutide | 32 | $28,833 |
| TrulicityDulaglutide | 20 | $19,115 |
| JardianceEmpagliflozin | 17 | $13,416 |
| JanuviaSitagliptin Phosphate | 11 | $12,518 |
| XareltoRivaroxaban | 14 | $12,116 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $10,610 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $6,286 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 28 | $6,200 |
| Levothyroxine Sodium | 215 | $2,881 |
| Atorvastatin Calcium | 216 | $1,858 |
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 26 | $1,836 |
| Estradiol | 35 | $1,601 |
| Gabapentin | 100 | $1,254 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 14 | $1,220 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $238 | $48,23849 claims |
| Novo NordiskOzempic | $218 | $28,83332 claims |
| MerckJanuvia, Janumet | $49 | $18,80423 claims |
| Boehringer IngelheimJardiance | $370 | $13,41617 claims |
| Johnson & JohnsonXarelto | $149 | $12,11614 claims |
| AstraZenecaBreztri Aerosphere | $414 | $10,61011 claims |
| GSKShingrix | $92 | $6,20028 claims |
| AbbVieSynthroid | $179 | $44218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 624 nurse practitioner providers in New Mexico.
Other nurse practitioner in Farmington
- Marisa EscobarAlbuquerque$36K
- Catherine SollerAlbuquerque$33K
- Ryan CommiskeySanta Fe$18K
- Lauren HeckethornRio Rancho$14K
- Christina ParksAlbuquerque$7K
- Laura DevorSanta Fe$6K
- Paula JohnsonAlbuquerque$6K
- Nadia Cano VazquezAlbuquerque$6K
- Laura LeblancAlbuquerque$6K
- Dina KotovaAlbuquerque$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.